Cyclodiode laser is an effective alternative to lensectomy in acute angle closure

Article

Using a cyclodiode laser to manage acute angle closure is a safe and effective alternative to emergency lensectomy or trabeculectomy

Using a cyclodiode laser to manage acute angle closure is a safe and effective alternative to emergency lensectomy or trabeculectomy, claims a study in the journal Eye.

Dr A. Manna et al., Birmingham Midland Eye Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK, conducted a retrospective case series on five patients with acute angle closure refractory to medical and laser treatment.

All participants underwent cyclodiode laser treatment. The team recorded each patient's demographic information, symptoms, medical and surgical treatment, visual outcomes and intraocular pressure (IOP).

Sufficient IOP control was not achieved with conventional management such as topical and systemic medical treatment, laser iridotomy and laser iridoplasty. Within 2 to 23 days of presentation of acute angle closure, emergency cyclodiode laser treatment was completed.

Lensectomy was performed in all patients at a later date, with final visual acuity of 6/12 or better with well-maintained IOPs. Just one patient required topical treatment and one patient developed persistent low-grade anterior uveitis.

Cyclodiode laser treatment is a successful alternative to managing acute angle closure for patients who do not respond to other treatments.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.